Fulvenat 250mg Injection: Effective Treatment for Medical Conditions

Uses:

• Treats hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in postmenopausal women.

Therapeutic Effects:

• Fulvenat 250mg Injection is an estrogen receptor antagonist that binds to the estrogen receptors in cancer cells and works by blocking the action of estrogen on cancer cells. This can slow or stop the growth of tumor cells.

Important Information:

• Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems.
• Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases.
• Fulvenat 250mg Injection is not indicated in children and adolescents under 18 years.
• Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.

Common Side Effects:

• Pain or inflammation at the site of injection
• Abnormal levels of liver enzymes
• Nausea
• Headache
• Cough
• Weakness or tiredness
• Joint and muscle pain
• Hot flashes
• Hair loss
• Skin rash

Serious Side Effects:

• Changes in heart rhythm
• Severe neutropenia (decreased WBC)
• Liver failure, inflammation of liver
• Hypersensitivity reaction
• Swelling in the body

Safety Advices:

• Pregnancy: Fulvenat 250mg Injection is unsafe to administer in pregnant women because it may affect the fetus.
• Breastfeeding: Breastfeeding is not recommended in patients taking Fulvenat 250mg Injection because the medicine passes into the breast milk in small amounts and may harm your baby.
• Lungs: It is unknown whether Fulvenat 250mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Fulvenat 250mg Injection is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in moderate liver failure.
• Alcohol: Consuming alcohol may affect the effectiveness of the Fulvenat 250mg Injection. Stop consuming alcohol if you are taking this medicine.
• Driving: Fulvenat 250mg Injection does not affect the ability to drive. Please consult your doctor for more advice.

How to Consume:

• It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do not self-administer the injection.
• Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors.

Storage:

• Store Fulvenat 250mg Injection in the refrigerator (2°C to 8°C).
• Do not freeze.
• Keep the injection away from the reach of children and pets.

FAQs:

1. What side effects should I report immediately while taking Fulvenat 250mg injection?
   • Allergic reactions like itching, swelling in your face or hands, tingling in mouth or throat, chest tightness, difficulty in breathing, fever, chills, cough, sore throat, body aches, unusual bleeding, bruising, or weakness should be informed to your doctor immediately.
2. How long should I have to take Fulvenat 250mg injection?
   • Fulvenat 250mg injection is given as a cycle therapy. Your doctor will decide the dose and duration of the therapy based on your disease severity and condition.
3. What if Fulvenat 250mg injection does not work for me?
   • There are alternative medicines that may work for you based on your disease condition and other factors. Your doctor will decide the alternative treatment that works best for you.
4. Does Fulvenat 250mg injection cause bone loss?
   • Fulvenat 250mg injection can cause side effects such as bone density loss and bone pain. If these side effects persist for a long time, consult a doctor.
5. Is there any special diet that I should follow while taking Fulvenat 250mg injection?
   • Unless your doctor advises you to avoid certain foods, follow a healthy diet. Please consult your doctor for more advice on food and diet.

Fact Box:

• Molecule name: Fulvestrant
• Therapeutic class: Antineoplastics
• Pharmacological class: Estrogen receptor antagonist
• Indications: Treat certain type of breast cancer in postmenopausal women

Tags: medical-injection, fulvenat, medicine, pharmaceutical, drug, 250mg